A detailed history of Eventide Asset Management, LLC transactions in Geron Corp stock. As of the latest transaction made, Eventide Asset Management, LLC holds 7,072,000 shares of GERN stock, worth $23.6 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares
7,072,000
Previous 6,356,182 11.26%
Holding current value
$23.6 Million
Previous $27 Million 19.13%
% of portfolio
0.57%
Previous 0.47%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.17 - $4.99 $2.98 Million - $3.57 Million
715,818 Added 11.26%
7,072,000 $32.1 Million
Q2 2024

Aug 13, 2024

BUY
$3.1 - $5.09 $19.7 Million - $32.4 Million
6,356,182 New
6,356,182 $27 Million

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.26B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Eventide Asset Management, LLC Portfolio

Follow Eventide Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eventide Asset Management, LLC with notifications on news.